{
  "pmcid": "12433822",
  "sha256": "a001526f60583fe6ab5960176c92f7338dd2cf2a91437bca618e949df00e87c9",
  "timestamp_utc": "2025-11-09T22:26:37.007803+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.208508771929825,
    "reading_ease": 23.275672514619913,
    "word_count": 152
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse reactions included phlebitis, hypersensitivity, foreign body granuloma, and endovenous glue-induced thrombosis."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 1,
    "max_score": 25
  }
}